This paper is in the following e-collection/theme issue:

Research Instruments, Questionnaires, and Tools (540) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1552) HIV/AIDS/STI Prevention and Care (816) LGBTQ Issues (414)

Published on in Vol 21, No 6 (2019): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13475, first published .
Development and Validation of a Personalized Social Media Platform–Based HIV Incidence Risk Assessment Tool for Men Who Have Sex With Men in China

Development and Validation of a Personalized Social Media Platform–Based HIV Incidence Risk Assessment Tool for Men Who Have Sex With Men in China

Development and Validation of a Personalized Social Media Platform–Based HIV Incidence Risk Assessment Tool for Men Who Have Sex With Men in China

Authors of this article:

Ke Yun1, 2, 3, 4 Author Orcid Image ;   Junjie Xu1, 2, 3, 4 Author Orcid Image ;   Sequoia Leuba5 Author Orcid Image ;   Yunyu Zhu6 Author Orcid Image ;   Jing Zhang1, 2, 3, 4 Author Orcid Image ;   Zhenxing Chu1, 2, 3, 4 Author Orcid Image ;   Wenqing Geng1, 2, 3, 4 Author Orcid Image ;   Yongjun Jiang1, 2, 3, 4 Author Orcid Image ;   Hong Shang1, 2, 3, 4 Author Orcid Image
Article Authors Cited by (13) Tweetations (5) Metrics

Ke Yun   1, 2, 3, 4 * , PhD ;   Junjie Xu   1, 2, 3, 4 * , PhD ;   Sequoia Leuba   5 , MPH, MD ;   Yunyu Zhu   6 , BSc ;   Jing Zhang   1, 2, 3, 4 , PhD ;   Zhenxing Chu   1, 2, 3, 4 , MPH ;   Wenqing Geng   1, 2, 3, 4 , MPH ;   Yongjun Jiang   1, 2, 3, 4 , MPH ;   Hong Shang   1, 2, 3, 4 , PhD

1 Key Laboratory of AIDS Immunology of National Health Commission of the People's Republic of China, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China

2 Key Laboratory of AIDS Immunology of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, China

3 Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, China

4 Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China

5 Department of Epidemiology, University of North Carolina, Chapel Hill, American Samoa

6 Hebei Yuanqiao Information Technology Co, Ltd, Shijiazhuang, China

*these authors contributed equally

Corresponding Author:

  • Hong Shang, PhD
  • Key Laboratory of AIDS Immunology of National Health Commission of the People's Republic of China
  • Department of Laboratory Medicine
  • The First Affiliated Hospital of China Medical University
  • No 155, Nanjing North Street, Heping District
  • Shenyang
  • China
  • Phone: 86 8328 2634
  • Email: hongshang100@hotmail.com